Laboratory for International Alliance on Genomic Research, Center for Integrative Medical Sciences, RIKEN, Yokohama, Japan.
Department of Life Sciences, Graduate School of Art and Sciences, the University of Tokyo, and Clinical Research Center, National Hospital Organization Sagamihara Hospital, Kanagawa, Japan.
Osteoarthritis Cartilage. 2016 May;24(5):835-43. doi: 10.1016/j.joca.2015.12.013. Epub 2015 Dec 31.
The aim of this work was to characterize the genome-wide DNA methylation profile of cartilage from three regions of tibial plateau isolated from patients with primary knee osteoarthritis (OA), providing the first DNA methylation study that reflects OA progression.
The unique model system was used to section three regions of tibial plateau: the outer lateral tibial plateau (oLT), the inner lateral tibial plateau (iLT) and the inner medial tibial plateau (iMT) regions which represented the early, intermediate and late stages of OA, respectively. Genome-wide DNA methylation profile was examined using Illumina Infinium HumanMethylation450 BeadChip array. Comparisons of the iLT/oLT and iMT/oLT groups were carried out to identify differentially methylated (DM) probes (DMPs) associated with OA progression. DM genes were analyzed to identify the gene ontologies (GO), pathways, upstream regulators and networks.
No significant DMPs were identified in iLT/oLT group, while 519 DMPs were identified in iMT/oLT group. Over half of them (68.2%) were hypo-methylated and enriched in enhancers and OpenSea. Upstream regulator analysis identified many microRNAs. DM genes were enriched in transcription factors, especially homeobox genes and in Wnt/β-catenin signaling pathway. These genes also showed changes in expression when analyzed with expression profiles generated from previous studies.
Our data suggested the changes in DNA methylation occurred at the late stage of OA. Pathways and networks enriched in identified DM genes highlighted potential etiologic mechanism and implicated the potential cartilage regeneration in the late stage of knee OA.
本研究旨在对源自原发性膝骨关节炎(OA)患者三个胫骨平台区域的软骨进行全基因组 DNA 甲基化特征分析,为反映 OA 进展的首次 DNA 甲基化研究提供依据。
本研究采用独特的模型系统对胫骨平台的三个区域进行分区:外侧胫骨平台(oLT)、内侧胫骨平台(iLT)和内侧胫骨平台(iMT),分别代表 OA 的早期、中期和晚期阶段。采用 Illumina Infinium HumanMethylation450 BeadChip 芯片对全基因组 DNA 甲基化谱进行检测。比较 iLT/oLT 和 iMT/oLT 组,鉴定与 OA 进展相关的差异甲基化(DM)探针(DMPs)。对 DM 基因进行分析,以鉴定基因本体论(GO)、途径、上游调控因子和网络。
在 iLT/oLT 组中未发现显著的 DMPs,而在 iMT/oLT 组中发现了 519 个 DMPs。其中超过一半(68.2%)呈低甲基化状态,并富集于增强子和 OpenSea。上游调控因子分析鉴定出许多 microRNAs。DM 基因富集于转录因子,尤其是同源盒基因和 Wnt/β-catenin 信号通路。这些基因在使用先前研究生成的表达谱进行分析时也显示出表达变化。
我们的数据表明,DNA 甲基化的改变发生在 OA 的晚期阶段。鉴定出的 DM 基因富集的途径和网络突出了潜在的发病机制,并暗示了晚期膝 OA 中潜在的软骨再生。